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Abstract
Background: The effects of proanthocyanidins (PACs), isolated from blackcurrant (Ribes nigrum
L.) leaves, on neutrophil accumulation during inflammatory processes were investigated in vivo and
in vitro.
Methods: In vivo studies were performed using carrageenin-induced pleurisy in rats pre-treated
with PACs. Exudate volume and PMNs accumulation were measured. Leukocyte cell adhesion
molecules (LFA-1, Mac-1 and VLA-4) mobilization in circulating granulocytes were analysed by flow
cytometry and endothelial cell adhesion molecules (ICAM-1 and VCAM-1) were detected by
immunohistochemistry on lung sections.
In vitro studies were conducted on endothelial LT2 cells, stimulated with TNF-α, to evaluate ICAM-
1, IL-8 and VEGF mRNA expression upon PACs treatment.
Data sets were examined by one-way analysis of variance (ANOVA) followed by a Scheffe post-
hoc test.
Results: Pretreatment of the animals with PACs (10, 30 and 60 mg/kg) inhibited dose-dependently
carrageenin-induced pleurisy in rats by reducing pleural exudate formation and PMNs infliltration.
Leukocyte cell adhesion molecules mobilization was not down-regulated on granulocytes by PACs.
Immunohistochemistry on lung sections showed a decreased production of endothelial cell
adhesion molecules.
In vitro experiments demonstrated that PACs were able to significantly inhibit ICAM-1 but not IL-
8 and VEGF165 mRNA expression. Moreover, VEGF121 mRNA expression was dose-dependently
enhanced.
Conclusion:  This study provides evidence to support the anti-inflammatory activity of
proanthocyanidins is related to an inhibition of leukocyte infiltration which can be explained at least
in part by a down-regulation of endothelial adhesion molecules, ICAM-1 and VCAM-1 and that
these compounds are capable of modulating TNF-α-induced VEGF transcription.
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Introduction
Cell-cell and cell-extracellular matrix interactions play a
central role in cell migration and leukocyte activation dur-
ing the inflammatory process. Leukocyte adhesion to the
endothelial cells and recruitment to extravascular tissue
are fundamental events in the pathogenesis of the inflam-
matory disease. All the steps in the recruitment cascade are
orchestrated by cell-adhesion molecules (CAMs)
expressed on both leukocytes and endothelial cells, and
different subsets of CAMs are responsible for the different
steps in leukocyte extravasation [1]. This cascade includes
the selectins, the integrins and members of the immu-
noglobulin superfamily. The expression of these adhesion
molecules is induced by various stimuli including
cytokines such as TNF-α, IL-1β, chemokines such as IL-8,
lipid mediators and peptides [2].
ICAM-1 (Intercellular Adhesion Molecule-1, also desig-
nated as CD54) and VCAM-1 (Vascular Cell Adhesion
Molecule-1, also designated as CD106) are members of
immunoglobulin superfamily involved in cell adhesion.
ICAM-1 is normally found on the surface of endothelial
cells, but its expression can be significantly increased
upon endothelial cell activation with cytokines or endo-
toxin. ICAM-1 binds to integrin members of the beta-1
subfamily such as LFA-1 (Lymphocyte Function-associ-
ated Antigen-1, also designated as CD11a/CD18) and
Mac-1 (Macrophage antigen-1, also designated as CD11b/
CD18). Leukocyte adhesion to ICAM-1 is performed by
LFA-1 upregulation and conformational change and by
Mac -1 mobilisation to the cell surface by fusion of storage
granules to the cell membrane [3]. VCAM-1, a transmem-
brane endothelial protein, is the counter-receptor of VLA-
4 (Very Late Antigen-4, also designated as α4β1 or
CD49d/CD29). This latter beta-1 integrin mediates the
adhesion of lymphocytes, monocytes, eosinophils and
natural killer cells to activated endothelial cells [4].
VEGF (Vascular Endothelial Growth Factor) and IL-8 are
two major mediators involved in inflammatory processes
associated with angiogenesis [5,6]. VEGF functions as an
endothelial growth and survival factor, it also increases
endothelial permeability [5] and is particularly relevant to
neutrophils emigration into the lung [7]. It causes vasodil-
atation through the nitric oxide synthase pathway in
endothelial cells [8] and can activate migration of neu-
trophils [7,9,10]. IL-8 stimulates the ability of neutrophils
to invade injured tissues. Besides its chemotactic influ-
ence, IL-8 also stimulates a rapid Mac-1 as well as LFA-1
expression on neutrophils which enables the adherence of
these cells to activated vascular endothelial cells [11].
Proanthocyanidins (PACs) are a group of biologically
active polyphenols, synthesized by many plants. PACs
isolated from blackcurrant (Ribes nigrum L.) leaves are
monomers and oligomers of flavan-3-ol units, the prodel-
phinidins and the procyanidins [12,13]. These com-
pounds have been reported to have anti-inflammatory
properties in vivo and in vitro [14-17]. We have previously
shown that PACs decrease the accumulation of circulating
leukocytes and plasma exudation during carrageenin
acute inflammatory reaction induced in rats. This anti-
inflammatory effect was associated with a reduction of
pro-inflammatory cytokines [18]. The current study was
undertaken to build on that previous finding and investi-
gate the effects of the PACs on adhesion molecules during
inflammatory processes.
Materials and methods
Proanthocyanidins
Proanthocyanidins from Ribes nigrum leaves were
extracted and isolated according to a previously described
method [12]. A voucher sample (RN 210590) has been
deposited in the Pharmaceutical Institute of Liège, Bel-
gium. Briefly, leaves were powdered separately and then
extracted at room temperature with acetone (70 % v/v in
water). The acetone was removed under vacuum at 40°C.
The resulting aqueous solution was freeze-dried. Isolation
of monomers and oligomers was carried out by MPLC on
reversed-phase RP8 with water-acetone (9:1) to obtain a
total proanthocyanidin-enriched fraction (PACs).
Carrageenin-induced pleurisy in rats
Animals
Mae Wistar rats, weighing 250 – 300 g were used. The ani-
mals were maintained on a standard laboratory diet with
free access to water. The experiments were conducted as
approved by the Animal Ethics Committee of the Univer-
sity of Liège, Belgium.
Carrageenin-induced pleurisy
Rats were pretreated with an intraperitoneal (i.p.) injec-
tion of saline or PACs (10, 30 or 60 mg/kg) 30 min before
the intrapleural injection of carrageenin. They were then
anaesthetized with ketamine HCl (75 mg/kg, i.p.) and car-
rageenin (0.2 ml, 10 mg/ml) or saline (0.2 ml) was
administered into the right pleural cavity. Each experi-
mental group contained 6 animals. Four hours later, the
animals were anaesthetized with sodium pentobarbital
(80 mg/kg, i.p.). The peritoneal cavity was opened and
blood (3–5 ml) was withdrawn into a heparinized syringe
from the inferior vena cava.
The chest was carefully opened and the pleural cavity
rinsed with 2.0 ml saline solution containing heparin (5
U/ml). Exudates and washing solutions were removed by
aspiration. Exudates with blood were rejected. The vol-
ume of the exudates was calculated by subtracting the vol-
ume of the washing solution (2.0 ml) from the total
volume recovered. A sample of each exudate was dilutedJournal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
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in phosphate buffer and polymorphonuclear leukocytes
count was performed using a hemocytometer.
After removal of the exudates, lungs were withdrawn and
fixed for one day under 30 cm pressure with 10% formal-
dehyde aqueous solution containing 0.480 M Na2HPO4
and 0.187 M KH2PO4 (pH 7.2) at room temperature. They
were then dehydrated by graded ethanol and embedded
in Paraplast.
Production of LFA-1, Mac-1 and VLA-4
The relative expression by circulating granulocytes of LFA-
1, Mac-1 and VLA-4 were measured using flow cytometry.
Granulocytes (200 000 cells) were stained by saturating
concentrations of monoclonal antibodies: R-PE-conju-
gated WT.1 against rat CD11a (0.1 µg per million cells),
FITC-conjugated WT.5 against CD11b (1 µg per million
cells) or FITC-conjugated MRα4-1 against CD49d (0.1 µg
per million cells).
After incubation of whole blood (40 µl), withdrawn into
a heparinized syringe from the inferior vena cava, for 20
min in the dark at room temperature, erythrocytes were
lysed with ammonium chloride buffer (30 min, in the
dark at room temperature). The cells were finally washed
three times with phosphate buffer saline containing 0.2%
bovine serum albumin and 0.09% sodium azide (pH
7.4), fixed with 4% paraformaldehyde in PBS and then
analyzed on a flow cytometer.
For this experiment, aspirin was used as a reference drug
and was administrated intraperitoneally to rats at 200 mg/
kg.
The antibodies were supplied by BD Pharmingen (Erem-
bodegem, Belgium).
Immunohistochemical localization of ICAM-1 and VCAM-1
Indirect immunohistochemical staining was performed
on 7 µm thick lung sections (2 sections per animal). After
deparaffinization with UltraClear, endogenous peroxi-
dase was quenched with 3% H2O2 in H2O for 10 min. The
sections were permeabilized with 0.1% Tween 20 in PBS
for 10 min and then incubated overnight with a 1/100 pri-
mary mouse anti-rat ICAM-1 monoclonal antibody or a 1/
500 primary mouse anti-rat VCAM-1 monoclonal anti-
body or with control solution (buffer alone). Specific
labelling was detected by incubating the sections 30 min
at room temperature with a 1/100 biotin-conjugated goat
anti-mouse IgG. Streptavidin-HRP complex was then
added to cover the tissue sections and incubated 30 min
at room temperature. DAB substrate was applied to the
sections, incubated for 5 min and finally washed in water.
Tissue sections were then counterstained with hematoxy-
lin-eosin, dehydrated and examined using light
microscopy.
The antibodies, streptavidin-HRP complex pre-diluted
and DAB substrate kit were supplied by BD Pharmingen
(Erembodegem, Belgium).
ICAM-1, IL-8 and VEGF mRNA expression in LT2 
endothelial cells
Cell culture
LT2 cell line originates from human umbilical vein
endothelium cells (HUVEC) which have been immortal-
ized by transfection with Large T SV40 antigen (a kind gift
of E. Dejana, Milan, to one of us BN). Cells were grown at
37°C in a humidified 95% air-5% CO2 atmosphere, using
2% pork skin gelatin-coated petri dish and RPMI 1640
medium supplemented with 10% FCS, 45 U/ml penicillin
and 45 µg/ml streptomycin.
Cytotoxicity of PACs on LT2 cells was previously tested
using the MTT assay (Sigma, Bornem, Belgium), based on
conversion by mitochondrial dehydrogenases of the sub-
strate (MTT) containing tetrazolium ring into the blue for-
mazan detectable spectrophotometrically [19]. The level
of blue formazan is then used as indirect index of cell den-
sity. The optical density of each sample was measured
with a microplate spectrophotometer reader at 560 nm.
Three replicates were used for each sample.
mRNA determination using RT-PCR
LT2 cells (100 000 cells), pretreated 24 h with PACs (10,
30 and 60 µg/ml) or with PBS (controls), were activated
in triplicate with TNF-α (5 ng/ml, 12 h). The medium was
then discarded and the cells frozen (-70°C). The level of
mRNA was determined using RT-PCR as described below.
RNA extraction
The total RNA was isolated using High Pure RNA Isolation
kit (Roche Applied Science, Penzberg, Germany). Briefly,
endothelial cells were treated by a lysis buffer which con-
tains guanidine hydrochloride. The lysates were laid on
filter tubes, where RNA was bound, and contaminating
DNA eliminated with DNase containing buffer. The
bound RNA was purified from salts, proteins and other
cellular impurities by washing steps and finally eluted in
water. Quantification of RNA was assayed by Ribo Green
RNA Quantification kit (Molecular Probes Europe BV, Lei-
den, The Netherlands) and RNA samples were diluted to
4 ng/µl.
One step RT-PCR
The one-step RT-PCR reactions were performed in dupli-
cate using the GeneAmp Thermostable rTth Reverse Tran-
scriptase RNA PCR kit (Applied Biosystems, Roche
Molecular Systems, New Jersey, USA), specific pairs ofJournal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
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primers (Table 1), 10 ng of total RNA and, when available,
a known copy number of an original synthetic internal
standard of RNA, in 25 µl reaction mixture [20].
The RT step (70°C, 15 min) was followed, after an initial
denaturation for 2 min at 95°C, by PCR amplification for
the adequate number of cycles and terminated by a final
elongation step of 2 min at 72°C. The PCR conditions for
amplification of ICAM-1 (30 cycles) and the 28S RNA (17
cycles) were: 94°C for 15 sec; 66°C for 20 sec; 72°C for
10 sec. For IL-8 (25 cycles), the conditions were: 94°C for
15 sec, 60°C for 30 sec, 72°C for 10 sec. For VEGF (32
cycles), the conditions were: 94°C for 20 sec, 66°C for 30
sec, 72°C for 1 min.
A 10 µl aliquot from each PCR reaction were subjected to
electrophoresis in 10% polyacrylamide gel and analysed
using a Fluor-S-MultiImager (BioRad, Hercules, Ca) after
staining with GelStar (FMC BioProducts, Rockland, ME,
USA) dye. The results were expressed in arbitrary units per
unit of 28S RNA. The 28S, ICAM-1 and VEGF primers
were commercially synthesized by Invitrogen (Merelbeke,
Belgium) and IL-8 primers by Eurogentec (Liège,
Belgium).
Statistical evaluation
Results are given as mean ± standard error of the mean
(s.e. mean) of N observations. Data sets were examined by
one-way analysis of variance (ANOVA) followed by a
Scheffe post-hoc test. A P-value of less than 0.05 was con-
sidered significant.
Results
Carrageenin-induced pleurisy
In control rats, the volume of the exudate collected 4 h
after carrageenin injection reached 0.98 ± 0.06 ml per rat
(n = 6) (Figure 1). This exudate contained a large number
of cells, mostly (> 95%) polymorphonuclear leukocytes
(PMNs). The total leukocyte number in the exudate was
88.53 ± 5.4 × 106 per rat (Figure 2). PACs (10, 30 and 60
mg/kg) significantly reduced the volume of the exudate in
a dose-dependent relationship (by, respectively, 31, 37
and 55%). Moreover, PMNs infiltration was also signifi-
cantly inhibited by PACs in a dose-dependent way (by,
respectively, 64, 73 and 75%).
Production of LFA-1, Mac-1 and VLA-4
In order to examine whether PACs affect the expression of
adhesion molecules on leukocytes during carrageenin-
induced pleurisy, the expression of three different mole-
cules: LFA-1 (CD11a/CD18), Mac-1 (CD11b/CD18) and
VLA-4 (CD49d/CD29) was measured by flow cytometry.
None of these molecules was significantly modulated dur-
ing carrageenin-induced pleurisy (Figure 3). Aspirin
reduced the level of VLA-4, as also did PACs at 10 mg/kg
(Figure 3C) but at 60 mg/kg PACs increased the expres-
sion of Mac-1 (Figure 3B) and VLA-4 (Figure 3C).
Immunohistochemical localization of ICAM-1 and VCAM-
1
Immunohistochemical analysis of lung sections obtained
from animals, treated with carrageenin alone, revealed
positive staining for ICAM-1 (Figure 4) and VCAM-1 (Fig-
ure 5). In contrast, sham group showed poor staining. In
lung tissue obtained from PACs pre-treated rats, immuno-
histochemical staining for ICAM-1 and VCAM-1 was
lower than those of positive control and disappeared with
the highest doses tested to reach negative control level at
60 mg/kg.
ICAM-1, VEGF and IL-8 mRNA expression
PACs were tested from 5 to 100 µg/ml on LT2 cells during
24 h and were not found to be significantly cytotoxic for
all the used doses. The effect of PACs on TNF-α-induced
ICAM-1, VEGF and IL-8 expression in LT2 cells was then
investigated. Basal ICAM-1, IL-8, VEGF121 and VEGF165
expression levels were low in unstimulated cells (Figure
6). Treatment of cells with TNF-α for 12 h significantly
increased the expression of ICAM-1, IL-8, VEGF121 and
VEGF165. Treatment of cells with PACs alone had no effect
on the basal expression of ICAM-1, VEGF and IL-8 genes
by LT2 cells (data not shown). A significant inhibition in
inducible ICAM-1 expression was observed in a dose-
dependent way in TNF-α stimulated cells (Figure 6A).
PACs did not significantly modify IL-8 (Figure 6B) nor
Table 1: Specific pairs of primers used for RT-PCR analysis.
Reverse (5'-3') Forward (5'-3')
28S -GATTCTGACTTAGAGGCGTTCAGT- -GTTCACCCACTAATAGGGAACGTGA-
ICAM-1 -TCCAGTTCAGTGCGGCACGAGAA- -CTGATGGGCAGTCAACAGCTAAAA-
IL-8 -GAATTCTCAGCCCTCTTCAAAAAC- -GCCAAGGAGTGCTAAAGAACTTAG-
VEGF -CTCACCGCCTCGGCTTGTCACA- -CCTGGTGGACATCTTCCAGGAGTA-Journal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
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VEGF165 (Figure 6D) expression in TNF-α stimulated cells
while it increased dose-dependently the expression of
VEGF121 (Figure 6C).
The downregulation effects of PACs on inducible ICAM-1
expression were not a result of cytotoxicity, because no
significant difference of viability was observed between
non-treated or PACs-treated cells (up to 100 µg/ml) using
the MTT assay.
Discussion
Our results confirm and extend previous data [14-16,18]
showing that proanthocyanidins (PACs) from Ribes
nigrum  leaves reduce carrageenin-induced pleurisy. The
volume of the exudate was dose-dependently diminished
by PACs. In this fluid, PACs decreased IL-1β, TNF-α,
CINC-1 and nitrite/nitrate levels [18]. Simultaneously,
the levels of leukocytes, mostly polymorphonuclear cells,
were decreased. The transvasation of leukocytes from
blood to the inflammatory exudate requires activation of
leukocytes and expression of adhesion molecules on the
surface of endothelial cells. We have examined both proc-
esses. PACs did not significantly reduce the expression of
adhesion molecules on the surface of leukocytes but
greatly reduced the production of adhesion molecules on
the surface of endothelial cells in vivo during carrageenin-
induced pleurisy.
Three adhesion molecules expressed by leukocytes were
examined. LFA-1 (CD11a/CD18) is not stored within the
leukocytes, its upregulation most likely results from a con-
formational change that allows the leukocyte to interact
with ICAM-1 [3]. All the animals treated with saline or
carrageenin in the pleural cavity or PACs showed the same
level of LFA-1 expression. This lack of difference could
depend on the fact that our antibody cannot differentiate
Effect of PACs on exudate volume during carrageenin-induced pleurisy Figure 1
Effect of PACs on exudate volume during carrageenin-induced pleurisy. At 4 h after intrapleural injection of carra-
geenin, the volume of the exudate was reduced by PACs (10, 30 and 60 mg/kg) administration. Each value is the mean ± s.e. 
mean of n = 6 experiments. °P < 0.01 versus saline. *P < 0.05 versus carrageenin. **P < 0.01 versus carrageenin.Journal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
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quiescent LFA-1 from activated LFA-1. On the other hand,
PACs did not reduce Mac-1, an inducible β2-integrin, but
increased its expression at high doses. While low doses of
PACs reduced VLA-4 expression, higher doses of PACs
increased its mobilization to the membrane. The
influence of PACs on adhesion molecules on leukocytes
was thus variable and cannot explain the reduction of leu-
kocyte accumulation in the pleural fluid.
In pulmonary tissue, our immunohistochemical studies
showed a dose-dependent decrease in the expression of
VCAM-1 and ICAM-1. These results were confirmed by the
examination of ICAM-1 production by LT2 endothelial
cells  in vitro. PACs dose-dependently reduced ICAM-1
mRNA production, suggesting that PACs inhibited ICAM-
1 production at the mRNA level. Previously, it was shown
that other compounds of the proanthocyanidin family
inhibit the expression of endothelial adhesion molecules,
in systemic sclerosis patients [21], in keratinocytes [22]
and in HUVEC [23]. In LT2 endothelial cells, the level of
ICAM-1 mRNA was increased 25-fold by TNF-α. This
overproduction would depend on the activation of NF-κB
or JNK/AP-1 transduction pathway. Previous results from
our laboratory (data not shown) have revealed that PACs
are able to inhibit NF-κB activation but at concentrations
10 times higher than the dose used to inhibit ICAM-1
mRNA expression in LT2 cells. On the other hand, com-
pounds from the proanthocyanidin family have been sug-
gested to inhibit the activation of JNK-1 and c-JUN [23].
Thus the inhibition of the expression of adhesion mole-
cules by PACs could be related to an interference of JNK/
c-JUN/AP-1 pathway activation.
The inhibition of ICAM-1 mRNA production by PACs was
rather specific as PACs did not reduce IL-8 mRNA and
VEGF mRNA in LT2 cells. Although, we have observed
Effect of PACs on PMNs infiltration during carrageenin-induced pleurisy Figure 2
Effect of PACs on PMNs infiltration during carrageenin-induced pleurisy. At 4 h after intrapleural injection of carra-
geenin, the accumulation of PMNs in the pleural cavity was dramatically inhibited by PACs (10, 30 and 60 mg/kg). Each value is 
the mean ± s.e. mean of n = 6 experiments. °P < 0.01 versus saline. **P < 0.01 versus carrageenin.Journal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
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Effect of PACs and aspirin on leukocyte cell adhesion molecules during carrageenin-induced pleurisy Figure 3
Effect of PACs and aspirin on leukocyte cell adhesion molecules during carrageenin-induced pleurisy. The rela-
tive expression by circulating granulocytes of LFA-1, Mac-1 and VLA-4 were measured using flow cytometry. Granulocytes 
were incubated with saturating concentrations of monoclonal antibodies (mAb): R-PE-conjugated WT.1 against rat CD11a 
(LFA-1) (A), FITC-conjugated WT.5 against CD11b (Mac-1) (B) or FITC-conjugated MRα4-1 against CD49d (VLA-4) (C). mAb 
against CD11a gave negative results for all tested groups. PACs induced up-regulation of CD11b and CD49d with the highest 
dose tested and down-regulation of CD49d with the lowest dose. Aspirin also down-regulated CD49d at 200 mg/kg. Each 
value is the mean ± s.e. mean of n = 6 experiments. *P < 0.05 versus carrageenin.Journal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
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Immunohistochemical localization of ICAM-1 in the lung Figure 4
Immunohistochemical localization of ICAM-1 in the lung. When compared to lung sections taken from sham group 
(A), lung sections from carrageenin-treated rats (B) demonstrated intense positive brown staining for ICAM-1 (black arrow). 
The degree of tissue staining for ICAM-1 from carrageenin-treated rats that had received PACs (10, 30 and 60 mg/kg, respec-
tively C, D and E) was markedly reduced. Original magnification: × 125. This figure is representative of six experiments per-
formed on different animals.Journal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
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Immunohistochemical localization of VCAM-1 in the lung Figure 5
Immunohistochemical localization of VCAM-1 in the lung. When compared to lung sections taken from sham group 
(A), lung sections from carrageenin-treated rats (B) demonstrated intense positive brown staining for VCAM-1 (black arrow). 
The degree of tissue staining for VCAM-1 from carrageenin-treated rats that had received PACs (10, 30 and 60 mg/kg, respec-
tively C, D and E) was markedly reduced. Original magnification: × 125. This figure is representative of six experiments per-
formed on different animals.Journal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
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that in vivo PACs inhibited CINC-1 production during car-
rageenin-induced pleurisy, these compounds did not
affect the production of similar molecules such as IL-8 by
LT2 endothelial cells. On the other hand, PACs interact
with VEGF mRNA expression in vitro. VEGF functions as
an endothelial growth and survival factors and also
increases vascular permeability [5]. It may play a relevant
role in neutrophil migration. Five human VEGF mRNA
species encoding VEGF isoforms of, among them, the
most abundant 121 and 165 amino acids are produced by
alternative splicing of VEGF mRNA [24]. The deletion in
VEGF121  begins at codon 116 of the mature form of
VEGF165  [24]. PACs did not influence expression of
VEGF165  mRNA but provoked an increase in VEGF121
expression. VEGF production is stimulated by cytokines
such as IL-6 [25], IL-1β [26] and TNF-α [27]. Up-regula-
tion of inducible VEGF in human HaCaT keratinocytes by
compounds from the proanthocyanidin family was also
observed by Khanna et al. [28,29], who correlated this
property to redox activity of these products. Proanthocya-
nidins are, in fact, known to display anti-oxidant and free
radical scavenging properties [30-34]. This effect of VEGF
up-regulation may have a beneficial role in regulating and
facilitating wound healing.
In conclusion, our current study provides evidence to sup-
port that the anti-inflammatory activity displayed by
proanthocyanidins from blackcurrant leaves is related to
down-regulation of endothelial adhesion molecules,
ICAM-1 and VCAM-1, probably through the transcription
Effect of PACs on TNF-α-induced ICAM-1, IL-8, VEGF121 and VEGF165 mRNA expression in human endothelial LT2 cells Figure 6
Effect of PACs on TNF-α-induced ICAM-1, IL-8, VEGF121 and VEGF165 mRNA expression in human endothelial 
LT2 cells. LT2 cells were pretreated with PACs (10, 30 and 60 µg/ml) or PBS for 24 h and then activated with 5 ng/ml TNF-α 
for 12 h. PACs dose-dependently inhibited mRNA expression of ICAM-1 (A), maintained IL-8 (B) and VEGF165 (D) and up-reg-
ulated dose-dependently VEGF121 mRNA expression (C). Gel electrophoresis of PCR products is shown under X-axis. Each 
value is the mean ± s.e. mean of three experiments analysed in duplicate each. °P < 0.01 versus negative control. *P < 0.05 ver-
sus positive control. **P < 0.01 versus positive control.Journal of Inflammation 2005, 2:9 http://www.journal-inflammation.com/content/2/1/9
Page 11 of 12
(page number not for citation purposes)
factor AP-1 regulation pathway. It would be of great inter-
est in the near future to determine the effect of PACs and
of similar compounds on the JNK/c-Jun/AP-1 regulatory
pathway. Moreover, PACs are capable of modulating
inducible VEGF transcription. The role of PACs in wound
healing still remains to be determined.
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